scholarly article | Q13442814 |
P356 | DOI | 10.1007/S00428-014-1578-6 |
P698 | PubMed publication ID | 24733561 |
P50 | author | Chao-Liang Wu | Q57246206 |
P2093 | author name string | Yuh-Shyan Tsai | |
Cheng-Huang Shen | |||
Yeong-Chin Jou | |||
Syue-Yi Chen | |||
Tzong-Shin Tzai | |||
Chen-Li Lai | |||
Chun-Liang Tung | |||
Hsin-Tzu Tsai | |||
Chang-Te Lin | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
Nuclear distribution of prothymosin alpha and parathymosin: evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replication | Q22254303 | ||
Prothymosin alpha in human blood | Q24605975 | ||
Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway | Q28581315 | ||
Cancer/testis antigens, gametogenesis and cancer | Q29616129 | ||
Prothymosin α enhances interleukin 2 receptor expression in normal human T-lymphocytes | Q34729463 | ||
Urothelial tumorigenesis: a tale of divergent pathways | Q36234720 | ||
Focus on TILs: Prognostic significance of tumor infiltrating lymphocytes in human bladder cancer. | Q36860110 | ||
Prothymosin α overexpression contributes to the development of pulmonary emphysema | Q36906886 | ||
Immunocytological and preliminary immunohistochemical studies of prothymosin alpha, a human cancer-associated polypeptide, with a well-characterized polyclonal antibody | Q36942477 | ||
European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update | Q37832571 | ||
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. | Q37859970 | ||
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update | Q37860472 | ||
Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma | Q38011495 | ||
Stress-induced non-vesicular release of prothymosin-α initiated by an interaction with S100A13, and its blockade by caspase-3 cleavage | Q39704112 | ||
Prothymosin alpha receptors on lymphocytes | Q40976451 | ||
Prothymosin alpha promotes cell proliferation in NIH3T3 cells. | Q42805123 | ||
Functional discontinuities in prothymosin alpha caused by caspase cleavage in apoptotic cells | Q42806913 | ||
Prothymosin alpha immunoactive carboxyl-terminal peptide TKKQKTDEDD stimulates lymphocyte reactions, induces dendritic cell maturation and adopts a beta-sheet conformation in a sequence-specific manner | Q43497809 | ||
Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines | Q45864362 | ||
Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease. | Q46445277 | ||
FOXP3 and survival in urinary bladder cancer. | Q51732343 | ||
Prothymosin alpha fragmentation in apoptosis. | Q52538048 | ||
The immunologically active site of prothymosin α is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients | Q62476897 | ||
Immunologic unreactivity in bladder cancer patients | Q70339979 | ||
Induction of tumor-specific T lymphocyte responses in vivo by prothymosin alpha | Q71703742 | ||
Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancer | Q72968585 | ||
Multiple tRNA attachment sites in prothymosin alpha | Q77889091 | ||
Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters | Q79258181 | ||
Aberrant prothymosin-alpha expression in human bladder cancer | Q81765414 | ||
Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer | Q82480819 | ||
Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma | Q83655754 | ||
Prognostic relevance of prothymosin-alpha expression in human upper urinary tract transitional cell carcinoma | Q84399270 | ||
P433 | issue | 6 | |
P304 | page(s) | 717-724 | |
P577 | publication date | 2014-04-15 | |
P1433 | published in | Virchows Archiv | Q19059548 |
P1476 | title | Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer | |
P478 | volume | 464 |
Q64071017 | Identification of prothymosin alpha (PTMA) as a biomarker for esophageal squamous cell carcinoma (ESCC) by label-free quantitative proteomics and Quantitative Dot Blot (QDB) |
Q39567209 | Prothymosin Alpha and Immune Responses: Are We Close to Potential Clinical Applications? |
Q64061300 | Prothymosin-α enhances phosphatase and tensin homolog expression and binds with tripartite motif-containing protein 21 to regulate Kelch-like ECH-associated protein 1/nuclear factor erythroid 2-related factor 2 signaling in human bladder cancer |
Q90003208 | The multifaceted immune regulation of bladder cancer |
Search more.